Uses of proton pump inhibitors and hypomagnesemia

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 5, 2012, Pages 553-559

  Gau, Jen Tzer ^a   Yang, Yu Xiao ^b   Chen, Roger ^a   Kao, Tzu Cheg ^c  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Hospitalized adults; Hypomagnesemia; Magnesium; Proton pump inhibitor

Indexed keywords

BICARBONATE; CALCIUM; CHLORIDE; CREATININE; MAGNESIUM; POTASSIUM; PROTON PUMP INHIBITOR; SERUM ALBUMIN; SODIUM;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHLORIDE BLOOD LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; HYPOMAGNESEMIA; LENGTH OF STAY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SIDE EFFECT; SMOKING; SODIUM BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALIZATION; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MAGNESIUM; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS;

EID: 84862815496     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3224     Document Type: Article

References (16)

1. Wright MJ, Proctor DD, Insogna KL, et al. Proton pump-inhibiting drugs, calcium homeostasis, and bone health. Nutr Rev 2008; 66: 103-108. DOI: 10.1111/nure.2007.66.issue-2
2. Yang YX, Metz DC. Safety of proton pump inhibitor exposure. Gastroenterology 2010; 139: 1115-1127. DOI: 10.1053/j.gastro.2010.08.023
3. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 2006; 355: 1834-1836.
4. Cundy T, Dissanayake A. Severe hypomagnesemia in long-term users of proton-pump inhibitors. Clin Endocrinol 2008; 69: 338-341. DOI: 10.1111/j.1365-2265.2008.03194.x
5. Shabajee N, Lamb EJ, Sturgess I, et al. Omeprazole and refractory hypomagnesemia. BMJ 2008; 337: a425. DOI: 10.1136/bmj.39505.738981.BE
6. Broeren MA, Geerdink EA, Vader HL, et al. Hypomagnesemia induced by several proton pump inhibitors. Ann Intern Med 2009; 151: 755-756.
7. Kuipers MT, Thang HD, Arntzenius AB. Hypomagnesemia due to use of proton pump inhibitors-a review. Neth J Med 2009; 67: 169-172.
8. Hoorn EJ, van der Hoek J, de Man RA, et al. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis 2010; 56: 112-116. DOI: 10.1053/j.ajkd.2009.11.019
9. Mackay JD, Bladon PT. Hypomagnesemia due to proton pump inhibitor therapy: a clinical case series. Q J Med 2010; 103: 387-395. DOI: 10.1093/qjmed/hcq021
10. Regolisti G, Cabassi A, Parenti E, et al. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor. Am J Kidney Dis 2010; 56: 168-174. DOI: 10.1053/j.ajkd.2010.03.013
11. Cundy T, Mackay J. Proton pump inhibitors and severe hypomagnesemia. Curr Opin Gastroenterol 2011; 27: 180-185.
12. Gau JT, Acharya U, Khan S, et al. Pharmacotherapy and the risk for community-acquired pneumonia: a case-control study of hospitalized older adults. BMC Geriatr 2010; 10: 45. DOI: 10.1186/1471-2318-10-45
13. Gau JT, Heh V, Acharya U, et al. Uses of proton pump inhibitors and serum potassium level. Pharmacoepidemiology Drug Saf 2009; 18: 865-871. DOI: 10.1002/pds.1795
14. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31: 166-170. DOI: 10.1038/ng889
15. Schlingmann KP, Waldegger S, Konrad M, et al. TRPM6 and TRPM7-Gatekeepers of human magnesium metabolism. Biochem Biophys Acta 2007; 1772: 813-821. DOI: 10.1016/j.bbadis.2007.03.009
16. Quamme GA. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol 2008; 24: 230-235.